casopitant

DRUG4 trials

Sponsors

GlaxoSmithKline

Conditions

Nausea and Vomiting, Chemotherapy-InducedNausea and Vomiting, PostoperativePostoperative Nausea and VomitingVomiting

Phase 1

Observational Pharmacokinetic Study Of GW679769 In Subjects With Renal Impairment

CompletedNCT00358813

GlaxoSmithKlineVomiting

Start: 2006-09-08End: 2008-08-22Updated: 2017-08-04

The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects

CompletedNCT00511823

GlaxoSmithKlineNausea and Vomiting, Chemotherapy-Induced

Start: 2007-07-23End: 2007-09-21Updated: 2017-08-03

Phase 3

Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women

CompletedNCT00334152

GlaxoSmithKlineNausea and Vomiting, Postoperative, Postoperative Nausea and Vomiting

Start: 2006-03-31End: 2006-07-31Updated: 2017-03-23

A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.

CompletedNCT00601172

GlaxoSmithKlineNausea and Vomiting, Chemotherapy-Induced

Start: 2008-03-10End: 2009-04-13Updated: 2018-01-17